Thomson Medical Group Ltd
SGX:A50
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.047
0.061
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Thomson Medical Group Ltd
Thomson Medical Group Ltd
Cost of Revenue
Thomson Medical Group Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Thomson Medical Group Ltd
SGX:A50
|
Cost of Revenue
-S$75.2m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Raffles Medical Group Ltd
SGX:BSL
|
Cost of Revenue
-S$45.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
16%
|
CAGR 10-Years
4%
|
|
|
I
|
ISEC Healthcare Ltd
SGX:40T
|
Cost of Revenue
-S$39.5m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-17%
|
|
|
O
|
Oue Lippo Healthcare Ltd
SGX:5WA
|
Cost of Revenue
-S$36.6m
|
CAGR 3-Years
-100%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-7%
|
|
|
A
|
Asia Vets Holdings Ltd
SGX:5RE
|
Cost of Revenue
-S$1.8m
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
24%
|
|
Thomson Medical Group Ltd
Glance View
Thomson Medical Group Ltd. engages in the healthcare and real estate business. The firm's healthcare business includes Thomson Medical Pte Ltd and TMC Life Sciences Berhad. The firm's segments include Hospital services, Specialised services and Investment holdings. Hospital services segment consists of provision of integrated medical healthcare facilities and services for primary, secondary and tertiary healthcare with focus on the areas of obstetrics and gynecology and pediatric services, diagnostic imaging services, pharmacy, 24-hour outpatient services, laboratory and services provided by outpatient clinics at the hospital. Its Specialised services segment includes services provided by the fertility clinics, pediatric centers, cancer center, cardiology center, Chinese medicine, specialist skin center and a pre-natal and clinical diagnostic laboratory. The company also includes a consumer business segment, consisting of products and services.
See Also
What is Thomson Medical Group Ltd's Cost of Revenue?
Cost of Revenue
-75.2m
SGD
Based on the financial report for Jun 30, 2024, Thomson Medical Group Ltd's Cost of Revenue amounts to -75.2m SGD.
What is Thomson Medical Group Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-6%
Over the last year, the Cost of Revenue growth was -27%. The average annual Cost of Revenue growth rates for Thomson Medical Group Ltd have been -15% over the past three years , -6% over the past five years .
You don't have any saved screeners yet
